Cargando…

Black tea and maintenance of normal endothelium‐dependent vasodilation: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006

Following an application from Unilever NV, submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Ireland, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scienti...

Descripción completa

Detalles Bibliográficos
Autores principales: Turck, Dominique, Bresson, Jean‐Louis, Burlingame, Barbara, Dean, Tara, Fairweather‐Tait, Susan, Heinonen, Marina, Hirsch‐Ernst, Karen Ildico, Mangelsdor, Inge, McArdle, Harry J, Naska, Androniki, Neuhäuser‐Berthold, Monika, Nowicka, Grażyna, Pentieva, Kristina, Sanz, Yolanda, Sjödin, Anders, Stern, Martin, Tomé, Daniel, Van Loveren, Henk, Vinceti, Marco, Willatts, Peter, Martin, Ambroise, Strain, Sean (J.J.), Siani, Alfonso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7009720/
https://www.ncbi.nlm.nih.gov/pubmed/32625684
http://dx.doi.org/10.2903/j.efsa.2018.5138
_version_ 1783495731099729920
author Turck, Dominique
Bresson, Jean‐Louis
Burlingame, Barbara
Dean, Tara
Fairweather‐Tait, Susan
Heinonen, Marina
Hirsch‐Ernst, Karen Ildico
Mangelsdor, Inge
McArdle, Harry J
Naska, Androniki
Neuhäuser‐Berthold, Monika
Nowicka, Grażyna
Pentieva, Kristina
Sanz, Yolanda
Sjödin, Anders
Stern, Martin
Tomé, Daniel
Van Loveren, Henk
Vinceti, Marco
Willatts, Peter
Martin, Ambroise
Strain, Sean (J.J.)
Siani, Alfonso
author_facet Turck, Dominique
Bresson, Jean‐Louis
Burlingame, Barbara
Dean, Tara
Fairweather‐Tait, Susan
Heinonen, Marina
Hirsch‐Ernst, Karen Ildico
Mangelsdor, Inge
McArdle, Harry J
Naska, Androniki
Neuhäuser‐Berthold, Monika
Nowicka, Grażyna
Pentieva, Kristina
Sanz, Yolanda
Sjödin, Anders
Stern, Martin
Tomé, Daniel
Van Loveren, Henk
Vinceti, Marco
Willatts, Peter
Martin, Ambroise
Strain, Sean (J.J.)
Siani, Alfonso
collection PubMed
description Following an application from Unilever NV, submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Ireland, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to black tea and maintenance of normal endothelium‐dependent vasodilation. The scope of the application was proposed to fall under a health claim based on newly developed scientific evidence. The food proposed by the applicant as the subject of the health claim is black tea beverages, either freshly prepared or reconstituted from water extract powders of black tea, characterised by the content of flavanols (expressed as catechins plus theaflavins) of at least 30 mg per 200 mL serving. The Panel considers that black tea characterised by the content of flavanols (expressed as catechins plus theaflavins) is sufficiently characterised. The claimed effect proposed by the applicant is ‘improvement of endothelium‐dependent vasodilation’. The Panel considers that maintenance of normal endothelium‐dependent vasodilation is a beneficial physiological effect. Of the five human intervention studies provided on the chronic effect of black tea consumption on endothelium‐dependent vasodilation, two investigated the effect after regular consumption of black tea for a sufficiently long time period (i.e. at least 4 weeks). These two studies did not allow an effect of black tea on endothelium‐dependent vasodilation to be established. The Panel concludes that a cause and effect relationship has not been established between the consumption of black tea and maintenance of normal endothelium‐dependent vasodilation.
format Online
Article
Text
id pubmed-7009720
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-70097202020-07-02 Black tea and maintenance of normal endothelium‐dependent vasodilation: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 Turck, Dominique Bresson, Jean‐Louis Burlingame, Barbara Dean, Tara Fairweather‐Tait, Susan Heinonen, Marina Hirsch‐Ernst, Karen Ildico Mangelsdor, Inge McArdle, Harry J Naska, Androniki Neuhäuser‐Berthold, Monika Nowicka, Grażyna Pentieva, Kristina Sanz, Yolanda Sjödin, Anders Stern, Martin Tomé, Daniel Van Loveren, Henk Vinceti, Marco Willatts, Peter Martin, Ambroise Strain, Sean (J.J.) Siani, Alfonso EFSA J Scientific Opinion Following an application from Unilever NV, submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Ireland, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to black tea and maintenance of normal endothelium‐dependent vasodilation. The scope of the application was proposed to fall under a health claim based on newly developed scientific evidence. The food proposed by the applicant as the subject of the health claim is black tea beverages, either freshly prepared or reconstituted from water extract powders of black tea, characterised by the content of flavanols (expressed as catechins plus theaflavins) of at least 30 mg per 200 mL serving. The Panel considers that black tea characterised by the content of flavanols (expressed as catechins plus theaflavins) is sufficiently characterised. The claimed effect proposed by the applicant is ‘improvement of endothelium‐dependent vasodilation’. The Panel considers that maintenance of normal endothelium‐dependent vasodilation is a beneficial physiological effect. Of the five human intervention studies provided on the chronic effect of black tea consumption on endothelium‐dependent vasodilation, two investigated the effect after regular consumption of black tea for a sufficiently long time period (i.e. at least 4 weeks). These two studies did not allow an effect of black tea on endothelium‐dependent vasodilation to be established. The Panel concludes that a cause and effect relationship has not been established between the consumption of black tea and maintenance of normal endothelium‐dependent vasodilation. John Wiley and Sons Inc. 2018-01-16 /pmc/articles/PMC7009720/ /pubmed/32625684 http://dx.doi.org/10.2903/j.efsa.2018.5138 Text en © 2018 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority. https://creativecommons.org/licenses/by-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nd/4.0/ (https://creativecommons.org/licenses/by-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited and no modifications or adaptations are made.
spellingShingle Scientific Opinion
Turck, Dominique
Bresson, Jean‐Louis
Burlingame, Barbara
Dean, Tara
Fairweather‐Tait, Susan
Heinonen, Marina
Hirsch‐Ernst, Karen Ildico
Mangelsdor, Inge
McArdle, Harry J
Naska, Androniki
Neuhäuser‐Berthold, Monika
Nowicka, Grażyna
Pentieva, Kristina
Sanz, Yolanda
Sjödin, Anders
Stern, Martin
Tomé, Daniel
Van Loveren, Henk
Vinceti, Marco
Willatts, Peter
Martin, Ambroise
Strain, Sean (J.J.)
Siani, Alfonso
Black tea and maintenance of normal endothelium‐dependent vasodilation: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
title Black tea and maintenance of normal endothelium‐dependent vasodilation: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
title_full Black tea and maintenance of normal endothelium‐dependent vasodilation: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
title_fullStr Black tea and maintenance of normal endothelium‐dependent vasodilation: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
title_full_unstemmed Black tea and maintenance of normal endothelium‐dependent vasodilation: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
title_short Black tea and maintenance of normal endothelium‐dependent vasodilation: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
title_sort black tea and maintenance of normal endothelium‐dependent vasodilation: evaluation of a health claim pursuant to article 13(5) of regulation (ec) no 1924/2006
topic Scientific Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7009720/
https://www.ncbi.nlm.nih.gov/pubmed/32625684
http://dx.doi.org/10.2903/j.efsa.2018.5138
work_keys_str_mv AT blackteaandmaintenanceofnormalendotheliumdependentvasodilationevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT turckdominique blackteaandmaintenanceofnormalendotheliumdependentvasodilationevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT bressonjeanlouis blackteaandmaintenanceofnormalendotheliumdependentvasodilationevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT burlingamebarbara blackteaandmaintenanceofnormalendotheliumdependentvasodilationevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT deantara blackteaandmaintenanceofnormalendotheliumdependentvasodilationevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT fairweathertaitsusan blackteaandmaintenanceofnormalendotheliumdependentvasodilationevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT heinonenmarina blackteaandmaintenanceofnormalendotheliumdependentvasodilationevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT hirschernstkarenildico blackteaandmaintenanceofnormalendotheliumdependentvasodilationevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT mangelsdoringe blackteaandmaintenanceofnormalendotheliumdependentvasodilationevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT mcardleharryj blackteaandmaintenanceofnormalendotheliumdependentvasodilationevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT naskaandroniki blackteaandmaintenanceofnormalendotheliumdependentvasodilationevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT neuhauserbertholdmonika blackteaandmaintenanceofnormalendotheliumdependentvasodilationevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT nowickagrazyna blackteaandmaintenanceofnormalendotheliumdependentvasodilationevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT pentievakristina blackteaandmaintenanceofnormalendotheliumdependentvasodilationevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT sanzyolanda blackteaandmaintenanceofnormalendotheliumdependentvasodilationevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT sjodinanders blackteaandmaintenanceofnormalendotheliumdependentvasodilationevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT sternmartin blackteaandmaintenanceofnormalendotheliumdependentvasodilationevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT tomedaniel blackteaandmaintenanceofnormalendotheliumdependentvasodilationevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT vanloverenhenk blackteaandmaintenanceofnormalendotheliumdependentvasodilationevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT vincetimarco blackteaandmaintenanceofnormalendotheliumdependentvasodilationevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT willattspeter blackteaandmaintenanceofnormalendotheliumdependentvasodilationevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT martinambroise blackteaandmaintenanceofnormalendotheliumdependentvasodilationevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT strainseanjj blackteaandmaintenanceofnormalendotheliumdependentvasodilationevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT sianialfonso blackteaandmaintenanceofnormalendotheliumdependentvasodilationevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006